Compounds > tx 3301
Page last updated: 2024-09-04

tx 3301 and telmisartan

tx 3301 has been researched along with telmisartan in 3 studies

Compound Research Comparison

Studies
(tx 3301)		Trials
(tx 3301)		Recent Studies (post-2010)
(tx 3301)		Studies
(telmisartan)		Trials
(telmisartan)		Recent Studies (post-2010) (telmisartan)
6915161,9304801,038

Protein Interaction Comparison

ProteinTaxonomytx 3301 (IC50)telmisartan (IC50)
Cytochrome P450 2C9 Homo sapiens (human)0.42
Type-1 angiotensin II receptorHomo sapiens (human)0.0179
Type-2 angiotensin II receptorHomo sapiens (human)0.0003
Cytochrome P450 2J2Homo sapiens (human)0.5
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.2589
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.8621

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diener, HC; Sacco, R; Yusuf, S1

Other Studies

3 other study(ies) available for tx 3301 and telmisartan

ArticleYear
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
    MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30

    Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine

2003
[PRoFESS study presented. Change in secondary prevention].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors

2003
Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:1-2

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Data Interpretation, Statistical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Telmisartan; Ticlopidine

2008